Article
Therapeutic Tumor Macrophage Reprogramming in Breast Cancer Through a Peptide-Drug…
medRxiv · 2024 · Lepland, A.; Peranzoni, E.; Haljasorg, U.; Asciutto, E. K.; Crespi-Amer, M.; Modesti, L.; Kilk, K.; Lombardia, M.; Acosta, G.; Royo, M.; Peterson, P.; Marigo, I.; Teesalu, T.; Scodeller, P.
Key facts
| Title | Therapeutic Tumor Macrophage Reprogramming in Breast Cancer Through a Peptide-Drug Conjugate |
|---|---|
| First author | Lepland, A.; Peranzoni, E.; Haljasorg, U.; Asciutto, E. K.; Crespi-Amer, M.; Modesti, L.; Kilk, K.; Lombardia, M.; Acosta, G.; Royo, M.; Peterson, P.; Marigo, I.; Teesalu, T.; Scodeller, P. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.08.12.607575 |
| Devices mentioned | K042152, K940422, K982100 |
| Product codes mentioned | CFN, DFZ, ICC, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1